Acronet   Report issue

For profit Phase 4
Founded: Tokyo Japan (2003)
Status: No NME R&D (2003)

Organization Overview

First Clinical Trial
2005
NCT00219570
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2005

Timeline

NOW
  • Now